NEW YORK – The European Commission on Monday approved Johnson & Johnson's subcutaneous Rybrevant (amivantamab) in two new dosing schedules as a first-line treatment for patients with advanced ...

The biotech is developing a drug aimed at a protein called PACAP, which has emerged as a potentially new way to prevent the onset of migraines.

Broome County is suffering from an outbreak of a bacterial infection that can cause extreme diarrhea and stomach pain. Broome ...

The gadopiclenol extension for use in infants and neonates offers high-quality MRI contrast enhancement at half the standard gadolinium dose. The FDA has approved an extension of intravenous ...

Intravenous use as a QIDP for adjunct treatment of complicated bacteremia caused by Staphylococcus aureus QIDP Designation provides for five years of market exclusivity ...

TSRA-196 is designed to precisely correct the genetic mutation underlying AATD, with the goal of restoring production of functional alpha-1 antitrypsin (AAT) protein through a one-time, durable ...

A single intravenous infusion of DMT, a fast-acting psychedelic compound found in the Amazonian brew ayahuasca, significantly ...

An urgent health warning has been issued to Sydneysiders as authorities grow increasingly concerned of a drug-resistant STI outbreak. Drug-resistant strains of gonorrhoea are now spreading across NSW, ...

Novel intravenous anti-inflammatory candidate advances to Phase I evaluation to assess safety, tolerability, and ...

Learn why nausea and vomiting can interfere with medication absorption during a migraine attack and discover which nonoral ...

NEW DELHI – The J&K Government on Thursday informed the Legislative Assembly that nearly 70,000 people — mostly youth — are involved in substance use in Kashmir, with around 50,000 identified as ...